Donnerstag, 25. Februar 2016 12:45 – 14

ID: 417
Human T cell receptor transgenic CD8+ T cells specifically kill HLA-A*0201/
CHM1+ Ewing sarcoma lines in vitro and in a preclinical mouse model
ID: 516
Thiel, U. (München)
The effects of sensorimotor training and whole body vibration on patients
suffering from chemotherapy-induced peripheral neuropathy
Streckmann, F. (Köln)
ID: 493
Sarcoma research by 3D cell culture | Becerikli, M. (Bochum)
ID: 521
ID: 555
Defektdeckungen am Capillitium: Therapieoptionen und perioperatives
Management | Kolbenschlag, J. (Bochum)
MeMa pilot study – effects of an exercise program for patients with
metastatic breast cancer | Wirtz, P. (Köln)
ID: 529
ID: 556
Freie Lappenplastiken nach Sarkomresektion – Überleben, Funktion, Lebensqualität | Kolbenschlag, J. (Bochum)
Routine nutritional evaluation and subsequent initiation of a case and
finding adapted nutritional therapy in the clinical-surgical daily – “Standard
Operating Procedure” (SOP) | Meissner, C. (Magdeburg)
ID: 557
Knapp oder weit? Welcher Sicherheitsabstand sollte bei Weichgewebssarkomen erzielt werden? | Kolbenschlag, J. (Bochum)
ID: 534
Corneale confokale Mikroskopie in der Frühdiagnostik Chemotherapieinduzierter Neuropathie (CIN) – eine Pilotstudie | Reinacher-Schick, A. (Bochum)
Donnerstag, 25. Februar 2016
Topic: Supportive Care
ID: 46
The relevance of nutritional treatment in cancer therapy | Heckel, M. (Thalmässing)
ID: 107
Patient satisfaction during treatment with Sancuso for CINV
12:45 – 14:15 Uhr
Topic: Breast Cancer
ID: 34
Moderate level of HER2 expression and its prognostic significance in breast
cancer with intermediate grade | Ignatov, A. (Magdeburg)
Evaluation of a multiprofessional cancer care model as contribution to
patient safety | Jansen, C. (Bonn)
ID: 40
Prognosis of breast cancer subtypes in routine clinical care
ID: 174
OncoBOS: Biosimilar epoetin alfa in patients with chemotherapy induced
anaemia – first analysis from a non-interventional German cohort study
ID: 65
Real-time long-term detection of circulating breast cancer cells induced by
medical interventions | Juratli, M. (Frankfurt/M.)
Bulenda, D. (Holzkirchen)
ID: 83
ID: 243
Primary prophylaxis of febrile neutropenia in female patients receiving
dose-dense biweekly chemotherapy in the clinical routine using long-acting
granulocyte colony-stimulating factors is safe and effective
Recurrence and survival of breast cancer patients depending on intrinsic
subtypes defined by surrogate parameters – a population-based analysis
ID: 84
Probability of metastatic disease at primary diagnosis according to different
intrinsic subtypes defined by surrogate parameters – a population-based
analysis of breast cancer patients | Schrodi, S. (München)
ID: 91
Prognostic impact of interferon regulating factor 4 (IRF4) in node-negative
breast cancer | Heimes, A. (Mainz)
ID: 97
Topotecan-induced ABCG2 expression in MCF-7 cells is associated with
decreased CD24 and EpCAM expression and a loss of tumorigenicity
ID: 118
Breast cancer and therapy in migrating and native women in Germany: is
there a difference? | von Au, A. (Heidelberg)
ID: 129
Evaluation of Option Grids to support shared decision-making in breast
cancer treatment | Scholl, I. (Hamburg)
ID: 130
The DETECT study concept – metastatic breast cancer and circulating tumor
cells | Schramm, A. (Ulm)
ID: 131
Factors predicting discordance in HER2 phenotype between primary tumor
and circulating tumor cells in women with metastatic breast cancer
ID: 135
Komplementärmedizin in der niedergelassenen Praxis | Rotmann, A. (Rodgau)
Maessen, D. (Düsseldorf)
ID: 171
Kurbacher, C. (Bonn)
ID: 255
The effect of a chemotherapy accompanying 4-week aerobic endurance
exercise intervention on incidence and severity of cancer related cognitive
impairments in leukemia patients. A randomized controlled trial.
Oberste, M. (Köln)
ID: 268
Internet as an appropriate medium for training support in cancer patients.
A systematic review of the literature | Pfirrmann, D. (Mainz)
ID: 323
Influence of a single exercise session on natural killer cell cytotoxicity and
tumor infiltration in preoperative esophageal carcinoma patients – a study
protocol | Schenk, A. (Köln)
ID: 402
Comparing different supportive measures – how cancer patients profit from
exercise and stress management | Wiskemann, J. (Heidelberg)
ID: 513
Thromboembolic events in hematological/oncological patients: diagnosis,
treatment patterns and adherence to treatment guidelines in clinical practice
Ostermann, H. (München)
ID: 515
Analysis concerning responsibility for rehabilitation sports in oncology
throughout Germany on federal state level | Giesen, A. (Köln)
32. Deutscher Krebskongress
24.– 27. Februar 2016 #dkk2016
Hennigs, A. (Heidelberg)
Schrodi, S. (München)
Brockhoff, G. (Regensburg)
Janni, W. (Ulm) 199
ID: 154
Disseminated tumor cells in luminal breast cancer: prognosis and treatment
ID: 360
eHealth acceptance in breast cancer care | Schindler, F. (München)
Stefanovic, S. (Heidelberg)
ID: 370
Cognitive function in relation to Aromatase inhibitors among breast cancer
survivors | Fersis, N. (Bayreuth)
ID: 379
Comparison of 12 weeks neoadjuvant Nab-Paclitaxel combined with
Carboplatinum vs. Gemcitabine in triple negative breast cancer:
WSG-ADAPT TN randomized phase-II-trial | Liedtke, C. (Lübeck)
ID: 383
Validation of a BRCAness test to select for targeted therapies in triplenegative breast cancer | Groß, E. (München)
ID: 396
Compelling evidence for FANCM as a breast cancer susceptibility gene
ID: 416
TREAT CTC: an innovative therapy approach to eliminate circulating tumor
cells (CTCs) | Tzschaschel, M. (München)
ID: 441
Characterization of circulating tumor cells regarding mutational status of
PIK3CA and expression of androgen receptor | Meier-Stiegen, F. (Düsseldorf)
ID: 173
Young breast cancer survivors – reproductive concerns, life satisfaction and
cancer-specific distress | Burgmann, M. (München)
ID: 189
Detection of EpCAM-negative circulating tumor cells in metastatic breast
cancer patients by using VyCAP filters technology | Lampignano, R. (Düsseldorf)
ID: 202
Provision of breast cancer care and survival in Germany – results from a
population-based high resolution study from Saarland
Holleczek, B. (Saarbrücken)
ID: 225
ID: 230
WSG BCIST study: Prosigna® results impact on adjuvant decision making in
early breast cancer (EBC) | Würstlein, R. (München)
Analysis of prognostication and treatment benefit tools for women with
early breast cancer as a prerequisite for informed shared decision making
Mühlbauer, V. (Hamburg)
Neidhardt, G. (Köln)
ID: 234
Phototheranostics immunoconjugates to detect eliminate triple negative
breast cancer cells | Hussain, A. (Aachen)
ID: 496
ID: 236
Brain metastases in Breast Cancer Network Germany (BMBC, GBG 79): the
introduction of the multicenter register and analysis of patient data
HER2 testing in neoadjuvant breast cancer trials – improved concordance of
HER2 status in different pathology laboratories | Pfitzner, B. (Berlin)
ID: 511
Comparison of tumor cell dissemination into the blood and bone marrow in
patients with primary breast cancer | Hartkopf, A. (Tübingen)
ID: 248
β-hydroxybutyrate inhibits growth of breast cancer cell lines
ID: 520
Eribulin 1,23 mg/m² an d1/8 q3w als Therapieoption beim fortgeschrittenen
metastasierten Mammakarzinom in der klinischen Anwendung
ID: 531
Treatment with Eribulin Mesylate infl uences expression of genes known to
induce malignant transformation in triple-negative breast cancer cell lines in
vitro | Bräutigam, K. (Lübeck)
ID: 536
Use of BSP II and HER2 as markers of breast cancer metastasis
ID: 548
5-year survival of young mothers with breast cancer | Waldmann, A. (Lübeck)
ID: 560
GAIN2: Adjuvant phase-III-trial comparing an intensifi ed dose-dense (idd)
adjuvant therapy with EnPC compared to a dose-dense (dd), dose-adapted
therapy with dtEC-dtD in patients with primary high-risk breast cancer:
results of the second safety interim a | Loibl, S. (Neu-Isenburg)
ID: 561
nab-Paclitaxel at a dose of 125 mg/m² weekly is more efficacious but less
toxic than at 150 mg/m². Results from the neoadjuvant randomized GeparSepto study (GBG 69) | Loibl, S. (Neu-Isenburg)
ID: 562
Higher rate of severe toxicities in obese patients receiving dose-dense (dd)
chemotherapy according to unadjusted body mass index – results of the
prospectively randomized GAIN study. | Loibl, S. (Neu-Isenburg) I
Laakmann, E. (Hamburg)
Bartmann, C. (Würzburg)
ID: 271
Prototypical implementation of an expert system supporting medical
documentation and clinical decision | Andrzejewski, D. (Flensburg)
ID: 279
EpCAM-independent enrichment of circulating tumor cells (CTCs) in
metastatic breast cancer | Schneck, H. (Düsseldorf)
ID: 294
Life satisfaction and life quality in the elderly patient with breast cancer
Wuerstlein, R. (München)
ID: 295
Possible role of estrogen receptor-alpha in the signaling mechanism of
progesterone receptor membrane component-1 in human breast cancer
ID: 296
Isolation and characterization of tumor infiltrating lymphocytes in primary
human breast cancer | Ugocsai, P. (Regensburg)
ID: 303
Frequent expression of PDL-1 on circulating epithelial tumor cells (CETCs)
could be a new therapeutic target in breast cancer patients
ID: 351
In vitro cultivation of circulating tumor cells of metastatic breast cancer
patients | Franken, A. (Düsseldorf)
ID: 358
TruRisk®-based next-generation sequencing reveals a high prevalence of
deleterious ATM mutations in BRCA1/2-negative breast and ovarian cancer
families | Heimbach, A. (Köln)
ID: 359
Ten years of mammography screening in North Rhine-Westphalia: analysis of
impact indicators | Heidrich, J. (Münster)
Benndorf, D. (Homburg/S.)
Widulle, D. (Heidelberg)
Neubauer, H. (Düsseldorf)
Pizon, M. (Bayreuth)
32. Deutscher Krebskongress
24.– 27. Februar 2016 #dkk2016
201
Topic: Developmental Therapeutics/Immunotherapy/Cellular Theraphy
Topic: Gynecologic Cancer
ID: 49
ID: 33
Survival advantage of lymphadenectomy in endometrial cancer – data from
Sachsen-Anhalt registry on 1502 patients with median follow-up of 78
months | Ignatov, A. (Magdeburg)
Frentsch, M. (Berlin)
ID: 41
Improvement in efficacy of Cetuximab, Panitumumab, Trastuzumab and
Rituximab by dianthin conjugation and co-application of SO1861
Fertility-sparing surgery (FSS) in patients with borderline ovarian tumors
(BOT) | Vdovichenko, N. (Essen)
ID: 76
Prognostic impact of conventional tumor grade in surgically treated FIGO
stage IB to IIB squamous cell cervical cancer | Horn, L. (Leipzig)
Immunomodulatory impacts of the novel HDAC inhibitor Resminostat
Prenzel, T. (Planegg-Martinsried)
ID: 69
ID: 212
CD40L: a new decisive antitumor effector function of CD8+ T cells
Panjideh, H. (Berlin)
ID: 331
Generation of new DNA- and protein vaccines for active immunotherapy
against MYCN-expressing neuroblastoma | Zumpe, M. (Greifswald)
ID: 77
ID: 335
Generation and characterization of a new chimeric human/mouse antiIdiotype antibody ganglidiximab for active immunotherapy against neuroblastoma | | Eger, C. (Greifswald)
Prognostic impact of tumor size using a cut-off value of 2 cm in surgically
treated FIGO stage IB cervical cancer | Horn, L. (Leipzig)
ID: 78
Peritumorale Entzündung beim Zervixkarzinom – prognoserelevant ??
ID: 80
KRAS and BRAF mutational analyses indicate monoclonal origin of peritoneal
implants and lymph node deposits in serous borderline ovarian tumors
(s-BOT) | Horn, L. (Leipzig)
ID: 106
Trends in surgery of squamous cell vulvar cancer patients over a 16-year
period (1998-2013): a population-based analysis | Rottmann, M. (München)
ID: 127
Prognostic and predictive values of primary vs secondary platinum resistance
for Bevacizumab treatment in platinum-resistant ovarian cancer in the
AURELIA trial | Trillsch, F. (Hamburg, Germany)
ID: 167
Human papillomavirus (HPV) vaccinated and still dysplasia
ID: 437
Colitis as an immune-mediated side effect of Ipilimumab treatment?!
ID: 440
“Small potpourri” of an immune-mediated side effect of Ipilimumab treatment of metastatic melanoma with difficult diagnostic challenge
Horn, L. (Leipzig)
Unger, S. (Greifswald)
Torz, M. (Greifswald)
Topic: Epidemiology
ID: 88
Subsequent malignancies among survivors of multiple myeloma in Germany:
cancer registry data-based analysis (1990-2011) | Baras, N. (Berlin)
ID: 165
Objections to be registered at the cancer registry of Baden-Württemberg
ID: 182
German and American lymphoma study and cancer registry data –
comparison of subtypes | Friedrich, S. (Heidelberg)
ID: 330
Reporting of colorectal cancer (ICD-10 C18-C21): decline in colorectal
cancer incidence does not apply to temporal anal cancer trends in Germany
Hahlbohm, U. (Hameln)
ID: 172
Retrospective analysis of compliance, compatibility and quality of life of
gynecological cancer patients under complementary treatment
ID: 184
Biomarker results from PENELOPE, a randomised phase-III-trial evaluating
chemotherapy (CT) ± Pertuzumab (P) for platinum-resistant ovarian cancer
(PROC) with low tumor HER3 mRNA expression | Marmé, F. (Heidelberg)
ID: 192
The risk of contralateral non-sentinel metastasis in patients with primary
vulvar cancer and unilaterally positive sentinel node | Prieske, K. (Hamburg)
ID: 193
Analytical validation of a CE marked companion diagnostic tumor test to
detect BRCA1 and BRCA2 mutations in ovarian cancer for clinical use
Hermann, S. (Heidelberg)
Buttmann-Schweiger, N. (Berlin)
ID: 334
“Cancer in Germany“ 2013 – current epidemiological cancer statistics
Bertz, J. (Berlin)
ID: 338
Trends of advanced breast cancer incidence rates after implementation of
the mammography screening program in the Regierungsbezirk (RB) Münster
Simbrich, A. (Münster)
ID: 347
ID: 409
Papillary type mostly accounts for rise in incidence rates of thyroid cancer in
Germany | Schönfeld, I. (Berlin)
How plausible is the causes of death statistics in cancers? | Belova, I. (Greifswald)
Wagner, A. (München)
Wehnelt, S. (München)
ID: 194
C-met is overexpressed in type I ovarian cancer – results of an explorative
analysis in a cohort of consecutive ovarian cancer patients
ID: 198
Circulating U2 small nuclear RNA fragments as a novel diagnostic tool for
patients with epithelial ovarian cancer | Kuhlmann, J. (1307)
ID: 200
Trends in prognostic factors and treatment of invasive cervical cancer
patients over a 16-year period (1998-2013): a population-based analysis
Battista, M. (Mainz)
Rottmann, M. (München)
32. Deutscher Krebskongress
24.– 27. Februar 2016 #dkk2016
203
ID: 224
Distribution pattern of node metastases in advanced ovarian cancer
ID: 539
The impact of age on comorbidity, toxicity of chemotherapy and survival in
recurrent ovarian cancer patients | Woopen, H. (Berlin)
ID: 545
Laparoskopische Corpus-und Cervixcarcinom-OPs: Erfahrungen eines
universitären Zentrums | Mavrova, R. (Homburg)
ID: 551
A simple and precise test towards prevention on HPV-induced cancers via
direct detection of the viral E6 oncoprotein | Schweizer, J. (Fremont, CA) ID
Bachmann, C. (Tübingen)
ID: 239
Influence of educational videos or information sheets on the levels of
knowledge and anxiety of patients consulting for cervical dysplasia
Schüler-Toprak, S. (Regensburg)
ID: 241
Salvage chemotherapy for heavily pretreated ovarian carcinoma or related
malignancies: high activity of oral Treosulfan combined with prolonged
lowdose infusional Gemcitabine is equal in both platinum-resistant and
potentially platinum-sensitive disease | Kurbacher, C. (Bonn)
ID: 256
Lifestyle changes in patients following the diagnosis of breast- and/or
gynecologic carcinoma | Wiedeck, C. (München)
ID: 306
Chemotherapy (CT) ± Pertuzumab (P) for platinum-resistant ovarian cancer
(PROC): AGO-OVAR 2.20/ENGOT-ov14/PENELOPE double-blind placebocontrolled randomized phase-3-trial | Mahner, S. (München)
ID: 343
Identifi cation of differentially activated signal transduction pathways in
platinum-resistant ovarian cancer | Naskou, J. (Düsseldorf)
ID: 447
Robot-assisted surgery in morbidly obese patients with endometrial cancer
Kurzeder, C. (Essen)
ID: 452
Management of recurrent and metastatic endometrial cancer in Germany:
results of the nationwide AGO pattern of care studies from the years 2013,
2009 and 2006 | Battista, M. (Mainz)
ID: 455
Comparison of Delphi Screener and Evalyn Brush self-samplers for HPV
screening in low resource settings (accessing*) | Krings, A. (Berlin)
ID: 457
SPECT/CT for preoperative SLN detection in vuvlar cancer: improved
detection and anatomical localization of SLN by three-dimensional
visualization | Klapdor, R. (Hannover)
ID: 471
Primary diffuse large B-cell lymphoma with manifestation in uterus: cases
duplicity in gynecological oncology 2015 | Barinoff, J. (Frankfurt/M.)
ID: 481
Experiences with off-lable use of Bevacizumab in patients with first-diagnosed locally advanced and metastatic cervical cancer | Wirtz, M. (Cologne)
ID: 505
A new tool for detection of HPV E7 proteins in cervical samples
Koch, I. (Neuried)
ID: 507
HER2/neu score as a prognostic factor for outcome in patients with triple
negative breast cancer | Schmidt, G. (Homburg)
ID: 509
A unique assay for verification of cervical cancer tests targeting specific
cytoskeletal biomarkers| Koch, I. (Neuried)
ID: 519
Langzeitanwendung von Eribulin 1,23 mg/m² und 1/8 q3w beim stark
vorbehandelten und fortgeschritten metastasierten Mammakarzinom – ein
Fallbericht | Benndorf, D. (Homburg)
ID: 522
Functionality of the tumor suppressor microRNA-1 in ovarian cancer
progression | Stope, M. (Greifswald)
32. Deutscher Krebskongress
24.– 27. Februar 2016 #dkk2016
Topic: Head and Neck Cancer
ID: 23
Improvement in survival in patients with oral squamous cell carcinoma
ID: 58
The value of the HPV status and its detection methods in oral and oropharyngeal squamous cell carcinomas – a meta-analysis | Götz, C. (München)
ID: 63
The oral cancer awareness campaign in Schleswig-Holstein: conceptual
background and design to increase early detection of oral cancer
ID: 64
In vivo detection of circulating tumor cells during tumor manipulation
Kreppel, M. (Köln)
Hertrampf, K. (Kiel)
Juratli, M. (Frankfurt/M.)
ID: 95
Ibuprofen and diclofenac restrict migration and proliferation of human
glioma cell lines in vitro | Leidgens, V. (Regensburg)
ID: 96
Isolation and characterization of human brain tumour initiating cells leading
invasion in an in situ migration model | Leidgens, V. (Regensburg)
ID: 102
Invasive head and neck cancer – data of a population-based clinical cancer
registry | Schlesinger-Raab, A. (München)
ID: 124
Deeskalationsstrategie beim Oropharynxkarzinom – Risikostratifikation an
einer prospektiv erfassten, primär chirurgisch therapierten Kohorte
Wittekindt, C. (Giessen)
ID: 139
Changes in macrophage polarization between diagnostic biopsy and tumor
resection in oral squamous cell carcinomas | Weber, M. (Erlangen)
ID: 146
Association of macrophage polarization with tumor outcome in early stage
oral squamous cell carcinomas | Wehrhan, F. (Erlangen)
ID: 185
Glukosestoffwechsel und Aggressivität des Mundhöhlenkarzinoms
Eckert, A. (Halle/S.)
ID: 186
Adenoid-zystisches Karzinom des Oberkiefers | Eckert, A. (Halle/S.)
ID: 206
Molekulare Parameter zur Rezidivkalkulation beim Plattenepithelkarzinom
der Mundhöhle | Kappler, M. (Halle(S))
ID: 214
Effect of Sorafenib on Cisplatin-based radiochemotherapy in head and neck
cancer cells | Möckelmann, N. (Hamburg)
ID: 216
Identification of functional proteomic signatures in HPV positive head and
neck cancer | Petersen, H. (Hamburg)
205
Treatment of recurrent or metastatic head and neck squamous cell
carcinomas (HNSCC) acoording to the EXTREME protocol in daily routine.
Survival outcomes compared to the EXTREME study results and conventional
chemotherapy. | | Münscher, A. (Hamburg)
Topic: Molecular Pathology
ID: 219
Importance of nodal yield in neck dissection: indicator of surgical and
oncological quality | Bier, J. (Hamburg)
ID: 460
ID: 235
Feasibility and results of radiotherapy (RT) or chemoradiation (RCT) for
unselected elderly patients with squamous cell carcinoma of the head and
neck (SCCHN) – a retrospective monoinstitutional study
Ioncopy: a novel method for calling copy number alterations in amplicon
sequencing data including significance assessment | Budczies, J. (Berlin)
ID: 468
Linking tumor evolution and therapy response using diagnostic targeted next
generation sequencing in colorectal cancer | Sers, C. (Berlin)
Hautmann, M. (Regensburg)
ID: 558
Molecular genetic analysis of primary CNS lymphoma (PCNSL) | Radke, J. (Berlin)
Vitamin D3 serum level influences lymphogenic metastasization as well as
natural killer cell-mediated cytotoxicity in patients with head and neck
squamous cell carcinoma | Bochen, F. (Homburg)
Topic: Pflegerische Beiträge
ID: 217
ID: 245
ID: 313
Identification of prognostic and predictive biomarkers in malignant pleural
mesothelioma in 134 patients from two research sites (Berlin and Essen)
Mairinger, F. (Berlin)
ID: 259
Two-year survival analysis of fifty consecutive head and neck squamous cell
carcinoma patients treated primarily with transoral robotic surgery (TORS) in
a single European academic centre | Lörincz, B. (Hamburg)
ID: 187
Staff retention and job satisfaction of non-medical personnel in oncology
practices | Osburg, S. (Köln)
ID: 136
Therapiebegleitendes Patientenhandbuch | Ludwig, N. (Heidelberg)
ID: 362
Erufosine causes cell cycle downregulation in head and neck cancer
ID: 344
Individualisierte Onkologie durch Digitalisierung – smart and safe!
Ansari, S. (Heidelberg)
ID: 378
Chemosensitivity of HPV-positive and HPV-negative HNSCC cell lines
Rieckmann, T. (Hamburg)
ID: 381
Radiosensitization of HPV-positive HNSCC cells through the inhibition of
Chk1 and Wee1 | Rieckmann, T. (Hamburg)
ID: 382
Characterization of tumor-associated blymphocytes in head and neck
squamous cell carcinoma | Lechner, A. (Köln)
ID: 432
Laboratory values as prognostic factors for the outcome of concurrent radiochemotherapy in the treatment of locally advanced head and neck cancers:
secondary results of two European randomized phase-III-trials (ARO 95-06,
SAKK 10/94) | Ghadjar, P. (Berlin)
ID: 449
Evaluation of hyperspectral imaging in early recognition of precancerous and
cancerous lesions in mouth and oropharynx | Laffers, W. (Bonn)
ID: 494
Influence of microRNA profi les and immune signatures on the effi cacy of
radiochemotherapy in locally advanced head and neck squamous cell
carcinoma | Heß, A. (Berlin)
ID: 538
Multimodale Therapie bei immunsupprimierten Patienten nach Organtransplantation mit fortgeschrittenem HNSCC des UICC-Stadiums IV – was ist
möglich? Eine Fallbeschreibung | Schedler, M. (Ramstein)
ID: 567
TCF-21-Hypermethylierung in Plattenepithelkarzinomen des Nasenvestibulums | Koopmann, M. (Münster)
ID: 568
Die Bedeutung von Nodal Yield bei der Neck Dissection: Chirurgischer und
onkologischer Qualitätsindikator | Bier, J. (Hamburg)
Elmer, A. (Berlin)
ID: 451
Parastomale Hautveränderungen unter zielgerichteter Antikörpertherapie
in der Onkologie – eine neue Ursache für parastomale Komplikationen und
deren pflegerischen Versorgungsschwierigkeiten? | Gruber, G. (München)
ID: 544
„Die Übelkeit hat mir meine Grenzen aufgezeigt“ – Erfahrung, Umgang
und Auswirkungen von Übelkeit bei Erwachsenen, die sich zuhause nach
ambulant verabreichten emetogenen Chemotherapien selbst versorgen: Eine
qualitative Studie | Mößner, U. (Gutach)
Topic: Radiation
ID: 51
Establishing high precision radiotherapy with flattening-filter-free techniques
in clinical routine – initial experiences in a single institution
ID: 297
Effective long-term local results and prognostic factors after fractionated
stereotactic radiotherapy of 257 intracranial meningeoma
Rieber, J. (Heidelberg)
Lubgan, D. (Erlangen)
ID: 372
The radiotherapy of glioblastoma might be enhanced by the addition of
chloroquine prior to irradiation. | Bühler, H. (Herne)
ID: 377
Motility as well as clonogenic survival of breast cancer and glioblastoma cells
is reduced by hyperthermia alone or in combination with irradiation.
ID: 466
Radiotherapy, bisphosphonates and surgical stabilization of complete or
impending pathologic fractures in patients with metastatic bone disease
Bühler, H. (Herne)
Fakhrian, K. (Herne)
32. Deutscher Krebskongress
24.– 27. Februar 2016 #dkk2016
207
ID: 467
Genital sparing with vaginal dilator for pelvic radiotherapy for female
patients | Fakhrian, K. (Wroclaw, Poland)
ID: 491
The therapeutic effect of photon irradiation on viable glioblastoma cells is
reinforced by hyperbaric oxygen. | Bühler, H. (Herne)
ID: 543
Proton beam irradiation for uveal melanoma | Joussen, A. (Berlin)
Freitag, 26. Februar 2016
12:45 – 14:15 Uhr
Topic: Cancer Prevention
ID: 178
Temozolomide resistance in human glioblastoma cell line U251 is caused by
mismatch repair deficiency and can be overcome by lomustine
ID: 218
Robo1-expression decreases the motility of irradiated glioma cells in vitro
ID: 240
Long-term outcome and prognostic factors of radiation therapy for
low-grade gliomas | Rieken, S. (Heidelberg)
ID: 270
Assessment of the use of complementary therapy in a cohort of Swiss
glioma patients | Eisele, G. (Zurich)
ID: 309
Be smart against cancer – a school-based program promoting cancer
awareness | Stölzel, F. (Dresden)
ID: 364
Feasibility assessment on a lifestyle intervention in healthy and diseased
BRCA 1/2 mutation carriers | Dukatz, R. (München)
Stritzelberger, J. (Erlangen)
Topic: Skin Cancer including Melanoma
ID: 54
ID: 117
Comparison of intensity-modulated radiotherapy (IMRT) and volumetric
modulated arc therapy (VMAT) in total scalp irradiation (TSI) of extensive skin
maligancies of the scalp | Ostheimer, C. (Halle)
Pembrolizumab in an advanced melanoma and immune suppressed patient
with a Churg-Strauss syndrome following Ipilimumab-induced colitis
Nguemgo Kouam, P. (Herne)
Maul, L. (Kiel)
ID: 350
Metastatic melanoma in pregnancy – a diagnostic and therapeutic challenge
Pföhler, C. (Homburg/Saar)
ID: 398
Difficult treatment of cutaneous T-cell lymphoma with a haematological
malignancy in medical history | Ahmed, M. (Greifswald)
ID: 434
Benchmarking of the DKG check list for inclusion criteria of BRCA testing
ID: 399
Atypical Fibroxanthoma (AFX) – a sarcoma or a Spindle cell carcinoma
(SpCC)?? | Kaisermayer, E. (Greifswald)
ID: 506
DNA repair in the defense against alkylation-induced colorectal
carcinogenesis | Kaina, B. (Mainz)
ID: 433
Challenges in treating in transit melanoma metastases and development of
new approaches. | PEDIADITI, P. (Greifswald)
ID: 319
Role of valproic acid or levetiracetam in survival of glioblastoma patients
ID: 472
HDAC1/HDAC2/HDAC3 mediated RAD51 and FANCD2 expression contribute to the resistance of melanoma cells to alkylating chemotherapeutics
ID: 395
Is a modification of the radiotherapeutic target volume necessary after
resection of glioblastomas with opening of the ventricles?
Rhiem, K. (Köln)
Happold, C. (Zurich)
Adeberg, S. (Heidelberg)
Roos, W. (Mainz)
ID: 495
The nerve growth factor receptor CD271 is crucial for stem-like properties of
melanoma cells and determines drug response | Redmer, T. (Berlin)
ID: 537
PD-1 blockade in nonmelanoma skin cancer | Winkler, J. (Heidelberg)
ID: 550
LDC-3 and PTPIP51 a winning team! | Chehab, R. (Gießen)
32. Deutscher Krebskongress
24.– 27. Februar 2016 #dkk2016
ID: 401
Are there correlations between clinical patient data and molecular expression
profiles of the key RTK/MAP kinase & AKT/mTOR signaling pathways in
human meningiomas? | Walter, J. (Jena)
ID: 406
FGFR1 seems to be a key regulator of pluripotency and/or differentiation in
meningiomas | Walter, J. (Jena)
ID: 442
Congenital deafness leading to the diagnosis of “atypical teratoid/rhabdoid
tumor (AT/RT)“ | Fasold, J. (Rostock)
ID: 445
Anaplastic meningiomas WHO grade III lack of somatic AKT1-mutations and
show an overexpression of EGF-receptor | Juratli, T. (Dresden)
209

Download Report